You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萬孚生物(300482.SZ):二個項目的產品推薦進入應急審批通道
格隆匯 02-20 15:28

格隆匯2月19日丨萬孚生物(300482.SZ)公佈,公司為積極應對新型冠狀病毒疫情防控的需求,積極組織團隊開展2019-nCoV新型冠狀病毒抗原、抗體檢測產品的研發,相關產品詳情請見公司於2020年2月3日發佈的《廣州萬孚生物技術股份有限公司關於新型冠狀病毒檢測試劑研製情況説明的公告》。

近日,公司收到了國務院應對新型冠狀病毒感染的肺炎疫情聯防聯控機制(科研攻關組)辦公室《關於推薦檢測試劑應急項目有關產品進入應急審批通道的函》,公司申報的適宜於疫情現場的新型冠狀病毒抗原快速檢測試劑、基於熒光微球/膠體金免疫層析技術新型冠狀病毒抗體快速檢測試劑,二個項目的產品推薦進入應急審批通道。

“生命重於泰山,疫情就是命令,防控就是責任”,萬孚生物積極投身新冠肺炎戰“疫”,充分發揮POCT領軍企業技術優勢,銘記社會責任,全力以赴與時間賽跑,加快成果在實戰中的應用,早日服務於疫情防控需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account